Prasanna Gore

About Prasanna Gore

Global Commercial Strategy Leader with 18+ years of leadership, industry, and management consulting experience in the biopharma industry focusing on business growth strategies across major therapeutic areas.• Served on the Board of Directors of Glenmark Pharmaceuticals India ($3.8 Billion Market Cap) from to 2006.• Deep rooted understanding of science and clinical matter with focused application to commercial objectives.• Strong commercial and scientific background with in-depth knowledge of the pharma/biotech space coupled with broad therapeutic area experience spanning CNS, Oncology, Cardiovascular, Immunology, Maternal and Women\'s Health, Dermatology, GI/Metabolic, and Rare Diseases.• Business area expertise in commercial analytics and strategy, new product planning and early commercialization, R&D and portfolio planning and strategy, therapeutic and disease area strategy, brand marketing and strategy, life-cycle management and launch planning, competitive landscape and SWOT analysis, unmet needs assessments, target product profiling, business opportunity assessment, business development and licensing evaluations, epidemiology and forecasting, and pricing and market access.• Led client teams on business planning and analysis, fostered strategic thinking, incorporated analytic insights, and contributed to C-suite level decision-making at both large and small biopharma firms.• Experience in leading cross-functional client teams, coordinating multidisciplinary projects, operating in complex matrix environments, and building strategic alliances with KOLs, R&D experts, academic researchers, and key stakeholders.• Considerable travel and work experience in international markets across North America, Europe, Japan, India, and China. Well versed with internationally diverse work cultures and social norms.• Performance driven forward-thinking executive with proven strategic, analytic, communication, and collaboration skills.

Experience

1. Founder and Chief Strategy Officer

   Pharmacompany, Inc

   May 2000 — Present · Boston, MA, US

   Founded a boutique strategy consulting firm and developed a client base which includes Fortune 500 as well as small biotech companies in U.S, EU, Japan, China, and India.Advised life-sciences start-ups and private equity/VCs in the United States, Europe, and Asia on business models, financing, and partnering.Experience in working with global brand teams, regional marketers, market research, medical affairs, BD and licensing, regulatory, pricing and market access, and corporate communications. Coordinated with R&D experts and thought leaders to gain scientific and market insights with a focus on identifying potential opportunities for new products, disease pathways, and treatment approaches.Involved in development and presentation of strategic and operational plans to several client senior leadership teams as part of annual budget cycles. Designed tools and strategic assessment frameworks for global clients aimed at identifying business development and licensing opportunities, business growth drivers, and priority disease indications.Experienced in facilitating the C-Suite and management boards in \"Go/No Go\" decision-making to optimize business portfolios.Formulated comprehensive therapeutic area strategies for large pharma clients with mid and long-term strategic imperatives to grow the business by defined revenue and CAGR objectives. Executed qualitative and quantitative primary market research, developed clinical trial cost models, informed clinical development decision-making, and worked on pricing and market access for global regulatory scenarios.Early stages of forming a start-up focused on an online platform for virtual biotech companies. Innovative and first of its kind business model that plans to link information, services, goods, and human capital to speed up drug discovery and commercial operations. We are excited about this innovation and look forward to sharing further details soon.

Education

• University of Bombay

  BPharm, Pharmacy

  1984 — 1988

• West Virginia University

  M.S., Pharmaceutical Marketing and Finance

  1989 — 1992

• West Virginia University

  PhD, Healthcare Marketing and Economics

  1992 — 1995

• DG Ruparel College of Arts, Science and Commerce

  Higher Secondary School Certificate, Science and Math

  1982 — 1984

• Holy Family High School

  Secondary School Certificate, Math and Science

  1975 — 1982

Skills

• R&D Planning and Portfolio Valuation
• Product Launch
• Dermatology
• Immunology
• Bio-Pharma Market Research
• Pharmaceutics
• Clinical Development Strategy
• Target Product Profile
• Vaccines
• Infectious Diseases
• M&a, Licensing, and Business Due Diligence
• Marketing
• Life Sciences
• Oncology
• Product Lifecycle Management
• Global Marketing
• Commercialization
• Sales Effectiveness
• Cancer
• Biopharmaceuticals
• Operational Excellence
• Leadership
• Product Life-Cycle Management
• Strategic Planning
• Product Development
• Start-Ups
• Clinical Trials
• Management Consulting
• Technology Valuation and Licensing
• Emerging Markets Advisor
• Disease and Therapeutic Franchise Strategy
• Business Development
• Clinical Research
• Financial Valuation of Drugs and Biologics
• Strategy
• Diabetes
• Identifying Mergers and Acquisitions Candidates
• Mergers and Acquisitions Research and Analysis
• Lifesciences
• Business Development and Licensing